Abstract
This Viewpoint discusses the benefits of expanded access research, the usefulness of expanded access data, the issues surrounding cost and transparency, and the adjusted role of institutional review boards.
| Original language | English |
|---|---|
| Pages (from-to) | 1057-1058 |
| Number of pages | 2 |
| Journal | JAMA |
| Volume | 329 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 4 Apr 2023 |